Thermosome demonstrates the power of targeted chemotherapy with the power of mild heating! congratulations to Pascal Schweizer , Prof. Lars Lindner and the entire team!
Exciting News from Thermosome! We are thrilled to share encouraging initial clinical data from Thermosome’s Phase I trial of THE001! Key highlights from the first and second dose levels: · 5 out of 6 efficacy-evaluable patients achieved local disease control · 4 out of 6 patients achieved Stable Disease (SD) per RECIST · One patient showed a Partial Response (PR) by Choi and 7 months of progression-free survival · PK profiles from dose level 1 confirmed the galenic principle of heat-triggered largely complete release of DOX from liposomes Thermosome is excited to continue advancing THE001 and its potential for other solid tumors. Stay tuned! Join us in the journey and learn more about this announcement at www.thermsome.com (https://lnkd.in/gvFA_rCn). #oncology #cancer #cancertargeting #sarcoma #softtissuesarcoma